InvestorsHub Logo
Followers 0
Posts 56
Boards Moderated 0
Alias Born 08/02/2021

Re: None

Thursday, 08/26/2021 1:53:23 PM

Thursday, August 26, 2021 1:53:23 PM

Post# of 1673
Cannacord Genuity Company Update - Strong clinical progress made for oral insulin in T2D and NASH

Maintains BUY rating and $30PT

https://www.oramed.com/wp-content/uploads/2021/08/Canaccord-Analyst-Report-08-24-2021.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ORMP News